S Korec

1.8k total citations
14 papers, 862 citations indexed

About

S Korec is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, S Korec has authored 14 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in S Korec's work include Neutropenia and Cancer Infections (5 papers), Complement system in diseases (5 papers) and Erythrocyte Function and Pathophysiology (3 papers). S Korec is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Complement system in diseases (5 papers) and Erythrocyte Function and Pathophysiology (3 papers). S Korec collaborates with scholars based in United States, Canada and Slovakia. S Korec's co-authors include Paul Katz, Tina Haliotis, John Roder, Margareta Klein, Paul V. Woolley, Philip S. Schein, James R. Jett, John R. Ortaldo, Anthony S. Fauci and Leonard Chiazze and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

S Korec

14 papers receiving 801 citations

Peers

S Korec

IMMUN

HEMAT

ONCOL

NEPHR

Hans‐Peter Lohrmann Germany

Shintaro Shiobara Japan

G Steiger Switzerland

Stephen R. Holdsworth Australia

M. A. Boogaerts Belgium

Bunshiro Akikusa Japan

P Miescher Switzerland

Hiroshi Tsutani Japan

Enrique H. Vallota United States

Shadduck Rk United States

Hans‐Peter Lohrmann Germany

S Korec

323 ×0.6

IMMUN

263 ×1.1

HEMAT

145 ×0.7

ONCOL

48 ×0.3

NEPHR

99 ×0.8

Citations per year, relative to S Korec S Korec (= 1×) peers Hans‐Peter Lohrmann

Countries citing papers authored by S Korec

Since Specialization

Citations

This map shows the geographic impact of S Korec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Korec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Korec more than expected).

Fields of papers citing papers by S Korec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Korec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Korec. The network helps show where S Korec may publish in the future.

Co-authorship network of co-authors of S Korec

This figure shows the co-authorship network connecting the top 25 collaborators of S Korec. A scholar is included among the top collaborators of S Korec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Korec. S Korec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Leo, Angelo Di, Stephen Chan, Marianne Paesmans, et al.. (2004). HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel. Breast Cancer Research and Treatment. 86(3). 197–206. 121 indexed citations

Kukučková, E., S. Špánik, E. Oravcová, et al.. (1996). Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Supportive Care in Cancer. 4(6). 427–434. 3 indexed citations

Snyder, Harry W., A Mittelman, Ayhan Oral, et al.. (1993). Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 71(5). 1882–1892. 83 indexed citations

Drgoňa, Ľuboš, et al.. (1993). Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.. PubMed. 40(2). 103–5. 1 indexed citations

Trupl, J., et al.. (1992). Ciprofloxacin plus Vancomycin versus Ceftazidime plus Gentamicin in the Treatment of Pneumonia in Granulocytopenic Patients with or without Venous Catheters. Chemotherapy. 38(4). 271–274. 3 indexed citations

Erickson, Bradley A., S Korec, James H. Keller, et al.. (1989). Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.. Journal of Clinical Oncology. 7(6). 781–789. 223 indexed citations

Choyke, Peter L., et al.. (1988). Cortical echogenicity in the hemolytic uremic syndrome: clinical correlation.. Journal of Ultrasound in Medicine. 7(8). 439–442. 10 indexed citations

Korec, S, Philip S. Schein, Frederick P. Smith, et al.. (1986). Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.. Journal of Clinical Oncology. 4(2). 210–215. 60 indexed citations

Korec, S, et al.. (1984). Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients.. PubMed. 3(3). 330–5. 8 indexed citations

10.

Korec, S, Ronald B. Herberman, Grace B. Cannon, James Reid, & James A. Braatz. (1981). Cytostasis of tumor cell lines by granulocytes from cancer patients and normal human donors. International Journal of Cancer. 28(2). 119–124. 6 indexed citations

11.

Klein, Margareta, John Roder, Tina Haliotis, et al.. (1980). Chediak-Higashi gene in humans. II. The selectivity of the defect in natural- killer and antibody-dependent cell-mediated cytotoxicity function. The Journal of Experimental Medicine. 151(5). 1049–1058. 87 indexed citations

12.

Korec, S, Ronald B. Herberman, Jack H. Dean, & Grace B. Cannon. (1980). Cytostasis of tumor cell lines by human granulocytes. Cellular Immunology. 53(1). 104–115. 42 indexed citations

13.

Roder, John, Tina Haliotis, Margareta Klein, et al.. (1980). A new immunodeficiency disorder in humans involving NK cells. Nature. 284(5756). 553–555. 211 indexed citations

14.

Babuŝíková, O, et al.. (1975). Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.. PubMed. 22(4). 413–21. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact